Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ameloblastoma × dabrafenib × Clear all

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 5 Thyroid Neoplasms 3 Neoplasms 2 Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation 1 Colorectal Neoplasms 1 Ameloblastoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06264778 2024-02-20

Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma

Shandong University

Phase 3 Unknown

Ameloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡